PubRank

Richard V Milani

Author PubWeight™ 129.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009 6.23
2 Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation 2010 3.83
3 Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. Circulation 2010 3.16
4 Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 2009 2.83
5 The obesity paradox, weight loss, and coronary disease. Am J Med 2009 2.25
6 Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. CA Cancer J Clin 2010 2.05
7 Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 2003 1.81
8 Obesity and cardiovascular disease: the hippocrates paradox? J Am Coll Cardiol 2003 1.80
9 Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the "obesity paradox". Mayo Clin Proc 2010 1.75
10 Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J 2013 1.53
11 Cardiac rehabilitation programs markedly improve high-risk profiles in coronary patients with high psychological distress. South Med J 2008 1.50
12 Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival. J Am Coll Cardiol 2002 1.46
13 Stopping stress at its origins. Hypertension 2007 1.44
14 Vitamin D and cardiovascular disease will it live up to its hype? J Am Coll Cardiol 2011 1.41
15 Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review. J Heart Lung Transplant 2009 1.41
16 Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin Proc 2009 1.33
17 Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis 2009 1.27
18 Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction. Am J Cardiol 2006 1.26
19 Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation 2004 1.24
20 Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol 2007 1.21
21 Adverse psychological and coronary risk profiles in young patients with coronary artery disease and benefits of formal cardiac rehabilitation. Arch Intern Med 2006 1.21
22 C-reactive protein and cardiovascular diseases--is it ready for primetime? Am J Med Sci 2009 1.20
23 Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the "obesity paradox". J Am Coll Cardiol 2012 1.16
24 Obesity and heart failure prognosis: paradox or reverse epidemiology? Eur Heart J 2004 1.12
25 Cardiac rehabilitation and exercise training in secondary coronary heart disease prevention. Prog Cardiovasc Dis 2011 1.10
26 Fish oils produce anti-inflammatory effects and improve body weight in severe heart failure. J Heart Lung Transplant 2006 1.10
27 Peak exercise oxygen pulse and prognosis in chronic heart failure. Am J Cardiol 2004 1.10
28 The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgrad Med 2008 1.09
29 Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies. Mayo Clin Proc 2013 1.09
30 Effects of cardiac rehabilitation and exercise training on autonomic regulation in patients with coronary artery disease. Am Heart J 2002 1.07
31 Prevalence of anxiety in coronary patients with improvement following cardiac rehabilitation and exercise training. Am J Cardiol 2004 1.05
32 Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev 2011 1.04
33 The role of fish oil in arrhythmia prevention. J Cardiopulm Rehabil Prev 2008 1.04
34 Body composition and coronary heart disease mortality--an obesity or a lean paradox? Mayo Clin Proc 2011 1.02
35 Atherosclerotic Vascular Disease Conference: Writing Group II: risk factors. Circulation 2004 1.00
36 Cardiac rehabilitation and exercise training programs in metabolic syndrome and diabetes. J Cardiopulm Rehabil 2005 1.00
37 Impact of exercise training on psychological risk factors. Prog Cardiovasc Dis 2011 0.99
38 Left atrial volume index predictive of mortality independent of left ventricular geometry in a large clinical cohort with preserved ejection fraction. Mayo Clin Proc 2011 0.96
39 Exercise capacity in adult African-Americans referred for exercise stress testing: is fitness affected by race? Chest 2004 0.94
40 Obesity paradox and the heart: which indicator of obesity best describes this complex relationship? Curr Opin Clin Nutr Metab Care 2013 0.92
41 The "obesity paradox": is smoking/lung disease the explanation? Chest 2008 0.92
42 Clinical implications of left atrial enlargement: a review. Ochsner J 2009 0.91
43 Fish oil in primary and secondary cardiovascular prevention. Ochsner J 2008 0.91
44 To B or not to B: is non-high-density lipoprotein cholesterol an adequate surrogate for apolipoprotein B? Mayo Clin Proc 2010 0.91
45 Impact of left ventricular geometry on prognosis-a review of ochsner studies. Ochsner J 2008 0.90
46 High-density lipoprotein cholesterol levels and prognosis in advanced heart failure. J Heart Lung Transplant 2009 0.90
47 Untangling the heavy cardiovascular burden of obesity. Nat Clin Pract Cardiovasc Med 2008 0.90
48 Safety and efficacy of cilostazol in the management of intermittent claudication. Vasc Health Risk Manag 2008 0.89
49 Psychological risk factors and cardiovascular disease: is it all in your head? Postgrad Med 2011 0.89
50 Cardiac rehabilitation and exercise therapy in the elderly: Should we invest in the aged? J Geriatr Cardiol 2012 0.89
51 Body composition and fitness in the obesity paradox--body mass index alone does not tell the whole story. Prev Med 2013 0.88
52 Disparate effects of obesity and left ventricular geometry on mortality in 8088 elderly patients with preserved systolic function. Postgrad Med 2009 0.88
53 Effects of cardiac rehabilitation and exercise training on indexes of dispersion of ventricular repolarization in patients after acute myocardial infarction. Am J Cardiol 2003 0.88
54 Ultrasound velocity criteria for renal in-stent restenosis. J Vasc Surg 2009 0.87
55 Relationships between the T-peak to T-end interval, ventricular tachyarrhythmia, and death in left ventricular systolic dysfunction. Europace 2012 0.87
56 Improvements in blood rheology after cardiac rehabilitation and exercise training in patients with coronary heart disease. Am Heart J 2002 0.86
57 Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients. J Cardiometab Syndr 2008 0.86
58 Shedding light on high-density lipoprotein cholesterol: the post-ILLUMINATE era. J Am Coll Cardiol 2008 0.86
59 The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management. Rev Cardiovasc Med 2008 0.85
60 Vitamin D and cardiovascular health. Circulation 2013 0.85
61 Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight loss. Ochsner J 2009 0.85
62 Secondary prevention of coronary heart disease in elderly patients following myocardial infarction: are all HMG-CoA reductase inhibitors alike? Drugs Aging 2008 0.84
63 Correlation and discrepancies between obesity by body mass index and body fat in patients with coronary heart disease. J Cardiopulm Rehabil Prev 2013 0.84
64 Beta-blockers as first-line antihypertensive therapy the crumbling continues. J Am Coll Cardiol 2009 0.83
65 Omega-3 fatty acids: a growing ocean of choices. Curr Atheroscler Rep 2014 0.83
66 Metabolic equivalent (MET) inflation--not the MET we used to know. J Cardiopulm Rehabil Prev 2007 0.82
67 Prevalence of hostility in young coronary artery disease patients and effects of cardiac rehabilitation and exercise training. Mayo Clin Proc 2005 0.82
68 Impact of obesity on outcomes in myocardial infarction combating the "obesity paradox". J Am Coll Cardiol 2011 0.82
69 Relation between left ventricular geometry and transmural dispersion of repolarization. Am J Cardiol 2005 0.82
70 Importance and management of dyslipidemia in the metabolic syndrome. Am J Med Sci 2005 0.81
71 Obesity, heart disease, and favorable prognosis--truth or paradox? Am J Med 2007 0.81
72 Relation of body fat categories by Gallagher classification and by continuous variables to mortality in patients with coronary heart disease. Am J Cardiol 2012 0.81
73 Value of weight reduction in patients with cardiovascular disease. Curr Treat Options Cardiovasc Med 2010 0.81
74 Aerobic and resistance exercise training in the elderly. Am J Geriatr Cardiol 2007 0.80
75 Dyslipidemia intervention in metabolic syndrome: emphasis on improving lipids and clinical event reduction. Am J Med Sci 2011 0.80
76 Homocysteine: the Rubik's cube of cardiovascular risk factors. Mayo Clin Proc 2008 0.80
77 Efficacy and safety of intensive statin therapy in the elderly. Am J Geriatr Cardiol 2008 0.80
78 The obesity paradox and discrepancy between peak oxygen consumption and heart failure prognosis--it's all in the fat. Congest Heart Fail 2007 0.80
79 Psychological factors and cardiac risk and impact of exercise training programs-a review of ochsner studies. Ochsner J 2007 0.80
80 Fish oil in cardiovascular prevention. Ochsner J 2002 0.80
81 The russert impact: a golden opportunity to promote primary coronary prevention. Ochsner J 2008 0.80
82 Impact of aging on hostility in coronary patients and effects of cardiac rehabilitation and exercise training in elderly persons. Am J Geriatr Cardiol 2004 0.80
83 Cardiac rehabilitation, exercise training, and psychosocial risk factors. J Am Coll Cardiol 2005 0.80
84 High-dose atorvastatin in acute coronary and cerebrovascular syndromes. JACC Cardiovasc Interv 2010 0.79
85 Relative importance of comorbid psychological symptoms in patients with depressive symptoms following phase II cardiac rehabilitation. Postgrad Med 2011 0.79
86 Exercise-based cardiac rehabilitation and improvements in cardiorespiratory fitness: implications regarding patient benefit. Mayo Clin Proc 2013 0.79
87 Body composition in coronary heart disease: how does body mass index correlate with body fatness? Ochsner J 2011 0.79
88 Benzocaine induced methemoglobinemia: a potentially fatal complication of transesophageal echocardiography. Ochsner J 2003 0.79
89 Benefits of exercise therapy in peripheral arterial disease. Prog Cardiovasc Dis 2011 0.78
90 Does fitness completely explain the obesity paradox? Am Heart J 2013 0.78
91 Lipid-lowering therapy for elderly patients at risk for coronary events and stroke. Am Heart Hosp J 2005 0.78
92 Is there an obesity, overweight, or lean paradox in coronary heart disease? Getting to the 'fat' of the matter. Heart 2013 0.78
93 Autonomic tone and benefits of cardiac rehabilitation programs. Mayo Clin Proc 2002 0.78
94 Statin wars: emphasis on potency vs event reduction and safety? Mayo Clin Proc 2007 0.78
95 Preventive cardiology and non-invasive cardiology research at the ochsner clinic foundation. Ochsner J 2006 0.78
96 Depression, autonomic function, and cardiorespiratory fitness: comment on Hughes, et al. (2010). Percept Mot Skills 2011 0.77
97 Peak oxygen consumption and heart failure prognosis--does race, sex, or fat explain the discrepancy? Congest Heart Fail 2009 0.77
98 Obesity and the heart: an ever-growing problem. South Med J 2003 0.77
99 Niacin therapy lives for another day-maybe? J Am Coll Cardiol 2013 0.77
100 C-Reactive Protein: How Has JUPITER Impacted Clinical Practice? Ochsner J 2009 0.77
101 Metabolic parameters derived from cardiopulmonary stress testing for prediction of prognosis in patients with heart failure: the ochsner experience. Ochsner J 2009 0.77
102 Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2002 0.77
103 Erectile dysfunction and cardiovascular disease. Postgrad Med 2011 0.77
104 The effects of statins on prevention of stroke and dementia: a review. J Cardiopulm Rehabil Prev 2012 0.77
105 New data on the clinical impact of exercise training, fish oils, and statins in heart failure. Phys Sportsmed 2009 0.77
106 Association of Left Ventricular Geometry With Left Atrial Enlargement in Patients With Preserved Ejection Fraction. Congest Heart Fail 2011 0.77
107 Metabolic syndrome, inflammation, and exercise. Am J Cardiol 2004 0.76
108 Metabolic syndrome, hostility, and cardiac rehabilitation. Am J Cardiol 2005 0.76
109 Exercise training as treatment of depression in heart failure. J Am Coll Cardiol 2012 0.76
110 Does inflammation influence cardiovascular risk factor modification? Circulation 2004 0.76
111 Cardiac rehabilitation and depression. Am J Cardiol 2004 0.76
112 The comprehensive management of anticoagulation: ochsner coumadin clinic. Ochsner J 2002 0.76
113 Multifactorial approach to the primary and secondary prevention of atherosclerosis. Ochsner J 2003 0.76
114 Generalized anxiety disorder. N Engl J Med 2004 0.75
115 Exercise training, cardiorespiratory fitness, and cardiovascular triggers. Am J Cardiol 2011 0.75
116 The "obesity paradox" in coronary heart disease. Am J Cardiol 2010 0.75
117 Efficacy and safety of sustained-release niacins. Am J Health Syst Pharm 2011 0.75
118 Exercise training and heart failure in older adults-dismal failure or not enough exercise? J Am Geriatr Soc 2009 0.75
119 Does the choice of statin really matter? Postgrad Med 2010 0.75
120 Cardiac rehabilitation, exercise training, and anxiety. J Am Coll Cardiol 2010 0.75
121 Gender, race and cardiac rehabilitation in the United States: is there a difference in care? Am J Med Sci 2014 0.75
122 Peak oxygen consumption and heart failure prognosis in women. J Am Coll Cardiol 2007 0.75
123 Cholesteryl ester transfer protein inhibition: the next frontier in combating coronary artery disease? J Am Coll Cardiol 2006 0.75
124 Optimal lipids, statins, and dementia. J Am Coll Cardiol 2005 0.75
125 Weight reduction and improvements in endothelial function: combating the "obesity paradox" in coronary heart disease. Chest 2011 0.75
126 Lipid therapy in the elderly--emphasis on clinical event reduction and safety. Am J Geriatr Cardiol 2006 0.75
127 Prevention of atherosclerosis. Postgrad Med 1995 0.75